nifekalant hydrochloride has been researched along with Complication, Intraoperative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, C; Gao, P; Lin, W; Wang, Q; Wu, Y | 1 |
| Iwasa, S; Sakaguchi, M; Shimamura, Y; Takemura, T; Tsuda, Y | 1 |
1 trial(s) available for nifekalant hydrochloride and Complication, Intraoperative
| Article | Year |
|---|---|
[The efficiency of nifekalant hydrochloride for the prevention of ventricular tachycardia during cardiac surgery].
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Surgical Procedures; Female; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome | 2004 |
1 other study(ies) available for nifekalant hydrochloride and Complication, Intraoperative
| Article | Year |
|---|---|
Intraprocedural Conversion Efficacy of Intravenous Nifekalant Administration for Persistent Atrial Fibrillation after Pulmonary Vein Isolation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; Electric Countershock; Female; Heart Atria; Humans; Infusions, Intravenous; Intraoperative Care; Intraoperative Complications; Male; Middle Aged; Organ Size; Peripheral Nerve Injuries; Phrenic Nerve; Progression-Free Survival; Prospective Studies; Pulmonary Veins; Pyrimidinones; Recurrence; Tachycardia, Ventricular; Treatment Outcome | 2020 |